Erika Chang

425 total citations
9 papers, 325 citations indexed

About

Erika Chang is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Erika Chang has authored 9 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 5 papers in Hematology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Erika Chang's work include Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Platelet Disorders and Treatments (3 papers). Erika Chang is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Platelet Disorders and Treatments (3 papers). Erika Chang collaborates with scholars based in Canada and United States. Erika Chang's co-authors include Paul R. Fortin, Carolyn Neville, Jeannine Kassis, Joyce Rauch, Diane Ferland, Michał Abrahamowicz, Lawrence Joseph, Lawrence Joseph, Murray B. Urowitz and Zhaleh Shariati‐Sarabi and has published in prestigious journals such as Journal of Clinical Epidemiology, Thrombosis and Haemostasis and Lara D. Veeken.

In The Last Decade

Erika Chang

9 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Chang Canada 8 270 141 80 49 43 9 325
Barbara Montaruli Italy 13 313 1.2× 256 1.8× 57 0.7× 51 1.0× 69 1.6× 32 444
Graciela S Cerrato Argentina 8 222 0.8× 172 1.2× 51 0.6× 35 0.7× 67 1.6× 11 303
G Thibaut France 4 267 1.0× 165 1.2× 56 0.7× 39 0.8× 47 1.1× 15 348
Vinicius Domingues United States 8 267 1.0× 135 1.0× 49 0.6× 59 1.2× 29 0.7× 12 335
Laya Blokzijl Netherlands 7 377 1.4× 222 1.6× 69 0.9× 45 0.9× 89 2.1× 8 440
Mercedes Pérez-Conesa Spain 5 188 0.7× 98 0.7× 58 0.7× 58 1.2× 39 0.9× 9 306
Linda K Barna United States 7 288 1.1× 266 1.9× 57 0.7× 47 1.0× 101 2.3× 9 417
Miguel Ángel Plasín Spain 5 281 1.0× 152 1.1× 95 1.2× 68 1.4× 26 0.6× 7 394
O Amengual Japan 5 251 0.9× 174 1.2× 103 1.3× 63 1.3× 18 0.4× 7 322
Virginie Dufrost France 10 272 1.0× 210 1.5× 39 0.5× 85 1.7× 33 0.8× 21 402

Countries citing papers authored by Erika Chang

Since Specialization
Citations

This map shows the geographic impact of Erika Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Chang more than expected).

Fields of papers citing papers by Erika Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Chang. The network helps show where Erika Chang may publish in the future.

Co-authorship network of co-authors of Erika Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Chang. A scholar is included among the top collaborators of Erika Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Chang. Erika Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Neville, Carolyn, Joyce Rauch, Jeannine Kassis, et al.. (2006). The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies. Lara D. Veeken. 45(9). 1116–1120. 6 indexed citations
2.
Chang, Erika, Christian A. Pineau, Sasha Bernatsky, et al.. (2006). Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.. PubMed. 33(9). 1780–4. 27 indexed citations
3.
Shariati‐Sarabi, Zhaleh, Erika Chang, Raja Bobba, et al.. (2005). Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis & Rheumatism. 53(4). 609–612. 59 indexed citations
4.
Kassis, Jeannine, Carolyn Neville, Joyce Rauch, et al.. (2004). Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Thrombosis and Haemostasis. 92(12). 1312–1319. 16 indexed citations
5.
Hudson, Marie, Joyce Rauch, Carolyn Neville, et al.. (2003). The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.. PubMed. 30(11). 2385–91. 38 indexed citations
6.
Neville, Carolyn, Joyce Rauch, Jeannine Kassis, et al.. (2003). Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.. PubMed. 90(1). 108–15. 57 indexed citations
7.
Neville, Carolyn, Joyce Rauch, Jeannine Kassis, et al.. (2003). Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thrombosis and Haemostasis. 90(7). 108–115. 61 indexed citations
8.
Chang, Erika, et al.. (2002). Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. Journal of Clinical Epidemiology. 55(5). 488–497. 43 indexed citations
9.
Chang, Erika, Michał Abrahamowicz, Diane Ferland, & Paul R. Fortin. (2002). Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.. PubMed. 29(11). 2350–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Montaruli Breakdown of academic impact, for papers by Graciela S Cerrato Breakdown of academic impact, for papers by G Thibaut Breakdown of academic impact, for papers by Vinicius Domingues Breakdown of academic impact, for papers by Laya Blokzijl Breakdown of academic impact, for papers by Mercedes Pérez-Conesa Breakdown of academic impact, for papers by Linda K Barna Breakdown of academic impact, for papers by Miguel Ángel Plasín Breakdown of academic impact, for papers by O Amengual Breakdown of academic impact, for papers by Virginie Dufrost
Rankless by CCL
2026